Brown Brothers Harriman & CO Exact Sciences Corp Transaction History

Brown Brothers Harriman & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $19,320 - $29,018	293 New	293 $19,000
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $191 - $296	6 New	6 $0
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $22,560 - $31,012	-250 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $22,148 - $29,451	-190 Reduced 43.18%	250 $33,000
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $10,592 - $17,622	190 Added 76.0%	440 $38,000
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $35,257 - $45,281	-454 Reduced 64.49%	250 $23,000
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $358 - $472	4 Added 0.57%	704 $83,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $27,891 - $43,425	450 Added 180.0%	700 $61,000
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $9,262 - $11,780	250	250 $12,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.